Royal Bank Of Canada Sensei Biotherapeutics, Inc. Transaction History

Royal Bank Of Canada

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.59 - $1.84 $114 - $356	194 Added 366.04%	247 $0
Q1 2024 Nov 05, 2024	SELL	$0.73 - $1.17 $141 - $226	-194 Reduced 78.54%	53 $0
Q1 2024 May 15, 2024	SELL	$0.73 - $1.17 $354 - $567	-485 Reduced 90.15%	53 $0
Q4 2023 Feb 14, 2024	BUY	$0.53 - $0.82 $154 - $238	291 Added 117.81%	538 $0
Q3 2023 Nov 14, 2023	SELL	$0.75 - $1.32 $168 - $297	-225 Reduced 47.67%	247 $0
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.81 $468 - $743	411 Added 673.77%	472 $0
Q1 2023 May 15, 2023	BUY	$1.31 - $1.7 $74 - $96	57 Added 1425.0%	61 $0
Q4 2022 Feb 14, 2023	SELL	$1.33 - $1.74 $97 - $127	-73 Reduced 94.81%	4 $0
Q3 2022 Nov 14, 2022	BUY	$1.55 - $2.24 $119 - $172	77 New	77 $0
Q2 2022 Aug 15, 2022	SELL	$1.49 - $2.3 $1,913 - $2,953	-1,284 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.22 - $6.07 $6,790 - $18,568	-3,059 Reduced 70.44%	1,284 $3,000
Q4 2021 Feb 14, 2022	BUY	$4.85 - $10.48 $9,370 - $20,247	1,932 Added 80.13%	4,343 $26,000
Q3 2021 Nov 15, 2021	BUY	$6.89 - $11.99 $11,933 - $20,766	1,732 Added 255.08%	2,411 $25,000
Q2 2021 Aug 16, 2021	BUY	$9.1 - $15.14 $6,178 - $10,280	679 New	679 $7,000

2.23M

Ticker SNSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,720,300
Market Cap $16M
Description
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.